SCANDINAV.CHEMOTECH CL.B
Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally. It operates in two divisions, Human Care and Animal Care. The company offers IQWave, an electroporation that generates a tumour-specific electrical stimulation; and veterinary medicines under the vetIQur name. Scandinavian Che… Read more
SCANDINAV.CHEMOTECH CL.B (8V6) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SCANDINAV.CHEMOTECH CL.B (8V6) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SCANDINAV.CHEMOTECH CL.B - Net Assets Trend (None–None)
This chart illustrates how SCANDINAV.CHEMOTECH CL.B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SCANDINAV.CHEMOTECH CL.B (None–None)
The table below shows the annual net assets of SCANDINAV.CHEMOTECH CL.B from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SCANDINAV.CHEMOTECH CL.B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SCANDINAV.CHEMOTECH CL.B Competitors by Market Cap
The table below lists competitors of SCANDINAV.CHEMOTECH CL.B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hoftex Group AG
MU:NBH
|
$3.44 Million |
|
Pentanet Limited
F:83K
|
$3.44 Million |
|
Peako Ltd
AU:PKO
|
$3.44 Million |
|
HPSIF
OTCQB:HPSIF
|
$3.44 Million |
|
Bina Darulaman Bhd
KLSE:6173
|
$3.43 Million |
|
ATAM VALVES ORD (BSE)
NSE:ATAM
|
$3.43 Million |
|
Greenbriar Capital Corp
PINK:GEBRF
|
$3.43 Million |
|
Yonga Mobilya Sanayi ve Ticaret AS
IS:YONGA
|
$3.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SCANDINAV.CHEMOTECH CL.B's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SCANDINAV.CHEMOTECH CL.B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SCANDINAV.CHEMOTECH CL.B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SCANDINAV.CHEMOTECH CL.B's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SCANDINAV.CHEMOTECH CL.B (8V6) | €- | N/A | N/A | $3.43 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |